Directory
>
Antonio Civitarese
Antonio Civitarese
Clinical Drug Combination Head, Clinical Research & Development | Intercept Pharmaceuticals
California, United States
Antonio Civitarese
Summary
Antonio Civitarese is a distinguished Biotech Development Executive with extensive experience in clinical and pre-clinical development, particularly in the realms of metabolic and rare diseases. His leadership at Intercept Pharmaceuticals showcases his expertise in drug combination development and program operations. With a strong foundation in biochemistry and molecular biology, he has successfully translated complex scientific objectives into actionable corporate strategies. Antonio is known for his innovative approach and ability to manage large-scale initiatives, enhancing project coordination and staff performance. His entrepreneurial spirit is reflected in his co-founding of Awaken Health and BioShore Partners, where he has been instrumental in advancing drug portfolio opportunities. Fluent in English, Italian, and Portuguese, he brings a global perspective to his work. Antonio's commitment to driving growth and innovation in biotechnology positions him as a key player in the industry.
Antonio Civitarese
Work Experience
Clinical Drug Combination Head, Clinical Research & Development at
Intercept Pharmaceuticals
September 2018 - Present
Formally Vice President, Executive Director, Sr Director, Director of Clinical Development at
Intercept Pharmaceuticals
September 2018 - Present
Co-Founder Obesity Clinic at
Awaken Health
July 2019 - December 2023
Founder, Metabolic Health at
Bio Nutrition LLC
September 2016 - January 2019
Director of Medical Affairs & Clinical Development at
La Jolla Pharmaceutical Company
October 2017 - September 2018
Scientific Director Metabolic Diseases at
Novo Nordisk
February 2015 - November 2016
Co-Founder, Partner and Scientific Adviser-Translational (Discovery & Clinical) at
Bioshore Partners
July 2014 - September 2015
Founder Metabolic Disease at
Exergy Biopharma LLC
September 2011 - December 2014
Director of Skeletal Muscle Metabolism (Pre-Clinical & Clinical) at
Pennington Biomedical Research Foundation
July 2011 - September 2014
Senior Investigator at Amylin Pharmaceuticals at
Amylin Pharmaceuticals
January 2010 - June 2011
Asst Professor at ASU/ Scientific Director - Metabolic Disease Group (Pre-Clinical & Clinical) at
Mayo Clinic
January 2008 - March 2010
Faculty Obesity and Diabetes (Pre-Clinical & Clinical) at
Pennington Biomedical Research Foundation
April 2002 - February 2008
Sr Scientist - Metabolic Diseases at
Chemgenex Pharmaceuticals
January 1998 - April 2002
Antonio Civitarese
Education
Rutgers University, Minor Mba Program
January 2009 - January 2009
Deakin University, Phd
January 1999 - January 2002
Deakin University, Msc & Bsc
January 1995 - January 1999
Redden College
Frequently Asked Questions about Antonio Civitarese
What is Antonio Civitarese email address?
Antonio Civitarese's primary email address is ******************@interceptpharma.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Antonio Civitarese work for?
Antonio Civitarese is a Clinical Drug Combination Head, Clinical Research & Development at Intercept Pharmaceuticals, a company specializing in Biological products, except diagnostic.
Where Antonio Civitarese graduated from?
Antonio Civitarese holds a degree in Biopharma Innovation from Rutgers University.
How can I directly contact Antonio Civitarese?
To contact Antonio Civitarese directly, you can use the email address ******************@interceptpharma.com. Complete contact information is available upon registration with Muraena.
Who is Antonio Civitarese?
Antonio Civitarese is a distinguished Biotech Development Executive with extensive experience in clinical and pre-clinical development, particularly in the realms of metabolic and rare diseases. His leadership at Intercept Pharmaceuticals showcases his expertise in drug combination development and program operations. With a strong foundation in biochemistry and molecular biology, he has successfully translated complex scientific objectives into actionable corporate strategies. Antonio is known for his innovative approach and ability to manage large-scale initiatives, enhancing project coordination and staff performance. His entrepreneurial spirit is reflected in his co-founding of Awaken Health and BioShore Partners, where he has been instrumental in advancing drug portfolio opportunities. Fluent in English, Italian, and Portuguese, he brings a global perspective to his work. Antonio's commitment to driving growth and innovation in biotechnology positions him as a key player in the industry.
Antonio`s contact details
******************@interceptpharma.com
***********@ljpc.com
********@pbrc.edu
***@elitebionutrition.com
Colleagues
SVP, Head Research and Development
VP, Regulatory and Quality Assurance
Senior Vice President Head of Human Resources
Senior Manager - Office of the CEO
Executive Director, Market Access, Strategic Accounts & Pricing
Vice President Regulatory Affairs
Executive Director, Head of Medical Research
Executive Director Human Resources
Executive Director - Financial Planning & Analysis
Vice President, Corporate Secretary